- Botox maker Allergan adds 'double-chin' drug with $2.1B deal Updated: Jun-17-15 10:24 am
NEW YORK - Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as "double chin".
- Botox maker appeals $6.75M verdict in cerebral palsy case Updated: Jun-10-15 8:35 am
BURLINGTON, Vermont - The maker of Botox has appealed a $6.75 million verdict in the case of a couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications.